The 109th Annual Meeting of the Radiological Society of North America (RSNA) was held on November 26, 2023 in Chicago, U.S.A. RSNA is a recognized the world’s top academic meeting which has the largest scale and the highest representativeness of the industry future direction in the global radiology community. Clinicians, professionals and exhibitors from many radiology groups, organizations and associations around the world gathered here. As a enterprise committed to becoming a global provider of total solutions of ultrasound intervention products, Leapmed also appeared at the event with the latest intervention consumable solutions for radiology imaging segments. 

Leapmed has been participating in RSNA since 2016. Through the opportunity of the academic conference, we understand the clinical users, study the European and American markets in depth, explore the clinical origins and development of interventional ultrasound, focus on the international clinical research trends, and build the cooperation platform in the United States and Europe to jointly develop and verify products for global market. 

It is Leapmed's original desire to make innovative development with focus on clinical needs and customer experience. In the past 6 years, Leapmed's R&D team has traveled to Chicago, Silicon Valley and Milwaukee, France, Germany and Turkey, Tel Aviv, Tokyo, South Korea and other countries and cities, we observed clinical procedures, learnt through the surgery technical support, and with a number of well-known hospital doctors to learn and communicate the latest developments in the medical imaging industry. In 2019, Leapmed formally started the development of the U.S. market and established the production center in Atlanta, from where, Leapmed product is presented in the international stage which takes this national brand to the innovative high land of the world. 

In recent years, Leapmed has initiated more than 30 patent applications in the United States, and has be granted 4 invention patent authorizations from the U.S. Intellectual Property Ofϐice. The biopsy guide products, histology biopsy and cytology biopsy needle series products, which can match various major ultrasound systems, have all obtained FDA notiϐications, and have successively entered into the Mayo Clinic, Cleveland Clinic, Hopkins Hospital and other toplevel general hospitals in the U.S. Leapmed® with USA certiϐications is growingly popular. 

Currently, Leapmed has obtained more than 150 global patent certiϐications and over 20 registration certiϐicates of NMPA, CE, FDA, PMDA, HAS and others. Leapmed's innovative products have entered more than 50 countries and regions around the world, and have landed in thousands of famous hospitals and institutions at home and abroad. The unceasing growth of Leapmed is backed by the comprehensive improvement of innovation and R&D strength, which also epitomizes the continuously improving internationalization level of China national brands.  

Transperineal prostate biopsy kit  

Throughout the global market, Leapmed full automatic core biopsy instrument and prostate biopsy kits with prostate biopsy guide attracted the most attention. The innovative design of the transperineal prostate biopsy guide enables the tight ϐitting of multiple endo-cavity probes, and allows the free selection of puncture positions, by which, the multiplanar puncture biopsy can be completed without the stepper. When used together with Leapmed's classic of full automatic biopsy needle, the guide can achieve quick sampling by one-click puncture.  

Disposable Biopsy Needle  

Persisting in independent innovation, Leapmed has developed two grades of sampling biopsy needles suitable for different sizes of tumor sampling needs, based on which, the in-situ cutting function has been added, which greatly improves the safety of puncture biopsy, and can satisfy the needs of puncture in breast, prostate, liver, kidney and other body parts. Doctors and distributors around the world who visited the booth showed great interest in product series. 

Disposable Puncture Needle 

Leapmed also brought a series of puncture needles for thyroid cytology biopsy, amniocentesis and chorionic villus puncture. The product is provided together with disposable sterile ultrasound gel, multi-speciϐication sterile transducer covers and other sensory control products, which offers one device kit for one patient to avoid cross infection. 

In the future, in the imaging intervention track, Leapmed will continuously research, develop and improve our products to launch the more comprehensive product portfolio. The company will pay the persistent attention to the trend of the global medical market with a forward-looking perspective, focusing on the overall solution of intelligent diagnosis and treatment of tumors, to achieve domestic substitution of imports and occupy a place in the international market.